Table 1.
Demographic and Clinical Characteristics
| Baseline Overall (n = 54) | Baseline for Those With Week 96 Data (n = 30) | Week 96 (n = 30) | |
|---|---|---|---|
| Age, y | 40 (31, 45) | 40 (36, 45) | 42 (38, 47) |
| White, non-Hispanic race | 39% | 43% | 43% |
| Male, sex | 89% | 93% | 93% |
| Current smoking | 26% | 23% | 20% |
| BMI, kg/m2 | 26.0 (22.0, 30.0) | 26.0 (24.0, 30.0) | 27.0 (25.0, 30.0) |
| Hypertension | 13% | 20% | 20% |
| Dyslipidemia | 11% | 13% | 20% |
| Viral hepatitis coinfection | 9% | 7% | 7% |
| CD4+ T lymphocyte count, cells per mm3 | 219 (70, 312) | 203 (70, 274) | 456 (342, 581) |
| HIV-1 RNA, log10 copies per mL | 4.8 (4.3, 5.3) | 4.8 (4.3, 5.3) | N/A |
| HIV-1 RNA >100,000 copies per mL | 35% | 37% | 0% |
| SAT area, cm2 | 199 (129, 303) | 192 (130, 335) | 223 (180, 361) |
| SAT density, HU | −100 (−106, −96) | −100 (−105, −97) | −104 (−107, −100) |
| VAT area, cm2 | 83 (54, 108) | 85 (69, 113) | 116 (65, 132) |
| VAT density, HU | −83 (−89, −78) | −84 (−90, −80) | −90 (−94, −84) |
| Adipocyte diameter, μm2 | 2156 (1909, 2439) | 2098 (1824, 2467) | 2759 (2304, 3029) |
Median (IQR) or percentage reported.
Abbreviations: BMI, body mass index; N/A, not applicable.